coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Eagle Bridge PCN, Cheshire East (LAD) · Health Inequalities Profile

    PCN U79049 · NHS Cheshire and Merseyside Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,634

    Registered population

    63.6% aged 18–64

    14.0%

    Aged 65+

    ICB 19.0% · England 17.9%

    8.2%

    Ethnic minority (non-White)

    3.5% Asian · England 9.6%

    38.0%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~17,087

    Core20 residents (est.)

    Resident basis; registered basis ~18,161 · see page 3

    6,430

    Hypertension register

    +5.55% in 3 yrs · England +5.60%

    452

    SMI register

    11.4% of Cheshire East (LAD)'s

    956

    COPD register

    Reviews +34.30% in 3 yrs

    Forecast to 2030

    7,395

    Hypertension patients, 2030

    +965 on today

    79.9%

    QRISK ≥20% on statins, 2030

    +5.00pp over 3 yrs

    3.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -8.7 pp
    Smoking cessation support offers fell over three years.

    Support offered fell 8.7 pp from 2023 to 2025 (England +0.1 pp) to 89.0% (England 94.2%), which may reflect review workflow gaps.

    63.2%
    Under-eighty blood pressure control trails England.

    Control in patients under 80 is 63.2% (England 67.8%) despite 89.4% having a recent reading, which could indicate treatment escalation gaps.

    68.7%
    Lipid therapy in high-risk patients exceeds comparators.

    Lipid-lowering therapy for QRISK ≥ 20% reaches 68.7% (England 63.6%; Cheshire East (LAD) 61.2%), rising +5.0 pp from 2023 to 2025 (England +3.8 pp).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population with 22.4% aged 0-17 contrasts with borough age patterns

    Eagle Bridge PCN serves 47,634 registered patients across two practices. The PCN has a younger profile: 22.4% are aged 0-17, above Cheshire East (LAD) (18.3%), the ICB (19.2%) and England (19.6%), while 14.0% are aged 65+, below Cheshire East (22.6%), the ICB (19.0%) and England (17.9%). Based on Census usual residents rather than registered patients, the non-White ethnic minority share is 8.2%. Projected list growth of 2.8% to 2030 (Cheshire East 3.4%, ICB 2.3%, England 2.3%) rests on an unverified methodology.

    Age profile

    0–1722.4%
    18–6463.6%
    65+14.0%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White91.8%
    Asian3.5%
    Mixed2.1%
    Other1.5%
    Black1.1%

    Older people · falls rows are Cheshire East (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire East LA)2,1292,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)72.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)51.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire East LA)9391,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire East LA)14.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 38.0% across the PCN and exceeds England at both practices

    Across Eagle Bridge PCN, 38.0% of registered patients live in the Core20 cohort, compared with 9.2% in Cheshire East (LAD), 31.9% in the ICB and 21.0% in England. Both practices exceed England: Millcroft Medical Centre records 38.9% (12,013 estimated patients) and Earnswood Medical Centre records 36.7% (6,148 estimated patients). Across associated areas, 17,087 residents live in deciles 1 and 2, including 11,423 aged 18-64 and 3,954 aged 0-17. This widespread deprivation is consistent with network-wide outreach rather than single-practice targeting, prioritising working-age and family prevention.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Millcroft38.9% · 12,013 patients
    Earnswood36.7% · 6,148 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    452

    SMI register

    0.91% recorded prevalence

    209

    Learning disability register

    0.42% recorded prevalence

    15

    Care homes, 735 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Cheshire East (LAD), Census 2021

    Recorded severe mental illness prevalence is 0.9% (452 patients), matching Cheshire East (0.9%) but below the ICB (1.1%) and England (1.0%). Learning disability prevalence is 0.4% (209 patients; Cheshire East 0.5%, ICB 0.6%, England 0.6%). Catchment care homes total 15 with 735 beds, though bed counts do not establish registered occupancy.

    Severe mental illness: physical health checks

    For severe mental illness, blood pressure checks were 79.4% (England 83.4%), BMI recording was 79.7% (England 82.1%), and alcohol checks were 79.4% (England 81.8%). These checks trail England, which audits could test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,430

    Hypertension register

    +5.55%

    Register growth, 3 yrs

    Cheshire East (LAD) +6.54% · England +5.60%

    +1.81pp

    BP control, under 80

    ≤140/90 · −1.38pp aged 80+

    +965

    More patients by 2030

    Forecast 7,395 (14.43%)

    Hypertension case-finding and control

    The PCN records 6,430 hypertension patients (crude prevalence 12.9%; England 15.2%). Recent blood pressure checks reach 89.4% (Cheshire East (LAD) 88.4%; England 90.0%), with Earnswood Medical Centre at 92.5% and Millcroft Medical Centre at 87.5%. However, blood pressure control under 80 is 63.2%, trailing Cheshire East (LAD) (66.6%), the ICB (66.4%) and England (67.8%), with Millcroft Medical Centre at 61.2% and Earnswood Medical Centre at 66.8%. Control at age 80 and over is 81.5% (England 81.2%). Lower control under age 80 than England despite high recording could reflect medication titration gaps, which clinical audits could test.

    Lipids and statins

    Lipid-lowering therapy for QRISK ≥ 20% reaches 68.7%, above Cheshire East (LAD) (61.2%) and England (63.6%), led by Earnswood Medical Centre at 72.9% and Millcroft Medical Centre at 65.9%. Higher uptake than England shows strong primary prevention reach that the PCN should sustain across both practices.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202675,697£1.60£1.71£1.86£121,115
    Cardiovascular (all), 2025100,514£3.27£4.37£3.33£328,681

    In 2026, the PCN prescribed 75,697 lipid-modifying items at £1.60 per item (England £1.86; ICB £1.71), spending £19,681 less than England's unit cost. Spending less per item than England reflects unit-cost differences, though unit cost does not establish prescribing efficiency or clinical appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +21.79%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.45%

    Asthma prevalence, PCN 3-yr % change

    Recorded asthma prevalence is 5.6% (2,612 patients; England 6.6%), while COPD prevalence is 1.9% (956 patients; England 1.9%). Over three years, review rates rose: asthma reviews increased +21.8% to 63.3% (England +4.4% to 65.7%), and COPD reviews rose +34.3% to 74.2% (England +2.8% to 76.4%). Across practices, asthma reviews range from 58.4% at Earnswood Medical Centre to 66.1% at Millcroft Medical Centre, leaving an estimated 959 patients unreviewed. This shortfall highlights a sizeable recall opportunity to sustain review gains.

    Cancer register and children's immunisation

    The cancer register records 1,611 patients (3.2% prevalence; England 3.8%). In Q1 2025/26 childhood immunisations, 12-month 6-in-1 coverage reached 96.3% (England 91.0%), exceeding the 95.0% target. However, age-five coverage falls to 84.3% for MMR dose 2 (10.7 pp below the 95.0% target; 6.4 pp below dose 1) and 81.4% for the 4-in-1 booster (13.6 pp below target). Lower age-five uptake could reflect recall gaps, which practice-level audits could test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.3%

    England 91.0%

    6-in-1 complete primary course at 24 months93.6%

    England 92.2%

    MMR dose 1 at 24 months90.0%

    England 88.3%

    MMR dose 2 at age 584.3%

    England 82.8%

    4-in-1 pre-school booster at age 581.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of cancers with a known stage (7,482 of 13,490) were diagnosed at stage 1 or 2, in line with England (55.3%) and 19.5 pp below the national ambition of 75.0% by 2028. Known-stage share was 72.8% (13,490 of 18,522 registered cancers), and early-stage share rose +2.6 pp from 2013 to 2022. Locally, PCN breast screening coverage is 63.3%, below Cheshire East (LAD) (74.5%) and England (69.9%). Cervical screening in women aged 25-49 is 66.7%, trailing Cheshire East (LAD) (73.6%). These system staging figures describe the wider ICB, not PCN performance. Lower screening uptake may delay early-stage case ascertainment across primary care.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Mid Cheshire Hospitals NHS Foundation Trust in Jul 2026 (provisional), the 62-day referral to treatment standard achieved 71.1% (130.5 of 183.5 pathways), 13.9 pp below the 85.0% standard, trailing NHS Cheshire and Merseyside Integrated Care Board (76.2%) and close to England (71.2%). The 28-day faster diagnosis standard reached 80.0% (1,743 of 2,180), exceeding the 75.0% standard. The 31-day combined treatment standard was 86.2% (125 of 145), below the 96.0% standard. For diagnostic tests, 12.7% waited 6+ weeks. These trust figures describe provider performance, not PCN performance.

    Pathways within standard (%)Mid Cheshireof North MidlandsEast CheshireCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)79.9580.6581.0877.2579.32
    31-day treatment (96%)86.2193.8596.3095.7192.50
    62-day referral to treatment (85%)71.1268.8453.4176.2371.16
    Diagnostic waits over 6 weeks (%)Mid Cheshireof North MidlandsEast CheshireEngland
    MRI5.1536.1326.6221.40
    CT1.092.8611.499.92
    Echocardiography5.5145.3926.2428.48
    Colonoscopy30.3446.5310.8530.83
    Gastroscopy31.8915.4910.2529.02
    All 15 DM01 tests12.7222.9416.1723.14
    Community services activityCheshire East residentsCheshire and Merseyside ICB
    Care contacts72,825541,280
    Referrals18,28097,150
    Patients with a contact21,910146,240

    Community services (residents of Cheshire East), Jun 2026 (provisional). For Cheshire East residents in Jun 2026 (provisional), experimental community data recorded 135,460 care activities, 72,825 care contacts, 21,910 patients with a contact, and 18,280 referrals. Adults aged 65+ accounted for 60.8% of contacts. These figures reflect submitting providers for borough residents, not unique PCN patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Immunisation achievement diverges by 29.3 pp while phone access trails England across both practices

    Clinical QOF achievement reached 100.0% at Millcroft Medical Centre and 98.4% at Earnswood Medical Centre (England 97.1%). In contrast, vaccination and immunisation achievement diverges by 29.3 pp, from 48.5% at Earnswood Medical Centre to 19.1% at Millcroft Medical Centre (England 55.2%). This divergence could reflect recording or recall differences, which practice-level audits could test.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Earnswood9836.727.4%72.0%73.1%
    Millcroft10138.930.6%78.2%65.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire East (LAD)AssetPCNCheshire East (LAD)
    Care homes (catchment)15 (735 beds)n/aSchools (catchment)71n/a
    Children's centres314Places of worship31272
    Libraries116Day centres (VCS)n/a1
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)741Primary academies1278
    Special schools25

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall clinic

    Asthma review coverage is 63.3% (Cheshire East (LAD) 64.5%; England 65.7%), leaving an estimated 959 of 2,612 patients unreviewed. For discussion, practices could run template-driven asthma review recall and offer flexible after-school or weekend slots across both practices. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Smoking cessation support pathway audit

    Smoking cessation support offered to patients with certain conditions is 89.0% (Cheshire East (LAD) 94.4%; ICB 95.2%; England 94.2%) after falling 8.7 pp over 2023 to 2025 (England +0.1 pp). Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Under-eighty hypertension titration review

    Blood pressure control under age 80 is 63.2% (Cheshire East (LAD) 66.6%; ICB 66.4%; England 67.8%), with Millcroft Medical Centre at 61.2% and Earnswood Medical Centre at 66.8%. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric capacity review (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Network Core twenty outreach model (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster catch up (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Screening uptake recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall clinic (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Smoking cessation support pathway audit (p12)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)MHIS · From Harm to Hope · Core20PLUS5 · 10YHP equity testPCN & Practice
    Option 3 · Under-eighty hypertension titration review (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15